A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

NCT01228045 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Trastuzumab in Combination with TS-ONE and cisplatin

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]